Virgin Galactic Announces Second Quarter 2022 Financial Results And Provides Business Update
Virgin Galactic Holdings, Inc. (NYSE: SPCE) reported a second quarter 2022 net loss of $111 million, worsening from $94 million a year earlier. Expenses rose with GAAP selling, general, and administrative costs at $45 million, and R&D expenses increasing to $62 million. Despite this, cash and cash equivalents stand at a robust $1.1 billion. Major developments include a partnership with Aurora Flight Sciences to construct two new motherships, with the first expected to be operational by 2025, and a new manufacturing facility in Arizona expected to be fully operational by late 2023, supporting upcoming commercial launches in Q2 2023.
- Strong cash position of $1.1 billion as of June 30, 2022.
- Partnership with Aurora to build two new motherships, enhancing operational capacity.
- New Delta class manufacturing facility in Arizona to produce up to six spaceships annually.
- Net loss increased to $111 million from $94 million year-over-year.
- R&D expenses escalated to $62 million, impacting profitability.
- Adjusted EBITDA of $(93) million, worsening from $(56) million in Q2 2021.
Advancement of Strategic Initiatives Positions the Company for Scaled Growth
-
Selected
Aurora Flight Sciences , a Boeing Subsidiary, to Build Two New Motherships; First Next-Generation Mothership Planned to Enter Service in 2025 -
Delta Class Spaceship Manufacturing Facility in
Phoenix Area , Expected to be Fully Operational in Late 2023 - Commercial Launch Anticipated for Q2 2023
Second Quarter 2022 Financial Highlights:
-
Cash position remains strong, with cash and cash equivalents and marketable securities of
as of$1.1 billion June 30, 2022 .
-
Net loss of
compared to a$111 million net loss in the second quarter of 2021.$94 million
-
GAAP selling, general, and administrative expenses of
, compared to$45 million in the second quarter of 2021. Non-GAAP selling, general and administrative expenses of$37 million in the second quarter of 2022, compared to$36 million in the second quarter of 2021.$26 million
-
GAAP research and development expenses of
, compared to$62 million in the second quarter of 2021. Non-GAAP research and development expenses of$35 million in the second quarter of 2022, compared to$59 million in the second quarter of 2021.$31 million
-
Adjusted EBITDA totaled
, compared to$(93) million in the second quarter of 2021.$(56) million
-
Net cash used in operating activities totaled
, compared to$(87) million in the second quarter of 2021.$(65) million
-
Free cash flow totaled
, compared to$(91) million in the second quarter of 2021.$(66) million
-
Cash paid for capital expenditures totaled
, compared to$5 million in the second quarter of 2021.$1 million
Business Highlights and Recent Updates:
-
On
July 6, 2022 , announced selection of Boeing subsidiary,Aurora Flight Sciences , to build two new motherships, each designed to fly up to 200 launches per year. The first new mothership is planned to enter service in 2025.
-
On
July 14, 2022 , announced new Delta class manufacturing facility inMesa, Arizona . This site is expected to have the capacity to produce up to six spaceships per year and is expected to be fully operational in late 2023, bringing hundreds of new highly skilled jobs to theGreater Phoenix area.
-
On
July 21, 2022 , announced partnership with Virtuoso to make a limited number of reservations withinVirgin Galactic's first 1,000 seats available to their exclusive global portfolio offering.
-
On
August 2, 2022 , announced expanded presence inNew Mexico to support scaled operations.
- Commercial service expected to launch in Q2 2023 due to extended completion dates within the mothership enhancement program.
Financial Guidance:
The following forward-looking statements reflect our expectations for the third quarter of 2022 as of
-
Forecasted free cash flow for the third quarter of 2022 is expected to be in the range of
to$(110) million .$(120) million
Conference Call Information
About
Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of federal securities laws with respect to
USE OF NON-GAAP FINANCIAL MEASURES (UNAUDITED)
This press release references certain financial measures that are not prepared in accordance with generally accepted accounting principles in
The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.
Second Quarter 2022 Financial Results
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited and in thousands except for per share data) |
||||||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Revenue |
|
$ |
357 |
|
|
$ |
571 |
|
|
$ |
676 |
|
|
$ |
571 |
|
|
|
|
|
|
|
|
|
|
||||||||
Operating expenses: |
|
|
|
|
|
|
|
|
||||||||
Customer experience |
|
|
122 |
|
|
|
63 |
|
|
|
147 |
|
|
|
63 |
|
Selling, general, and administrative |
|
|
44,700 |
|
|
|
36,916 |
|
|
|
81,707 |
|
|
|
80,235 |
|
Research and development |
|
|
62,340 |
|
|
|
34,619 |
|
|
|
114,167 |
|
|
|
69,708 |
|
Depreciation and amortization |
|
|
2,915 |
|
|
|
2,871 |
|
|
|
5,767 |
|
|
|
5,740 |
|
Total operating expenses |
|
|
110,077 |
|
|
|
74,469 |
|
|
|
201,788 |
|
|
|
155,746 |
|
|
|
|
|
|
|
|
|
|
||||||||
Operating loss |
|
|
(109,720 |
) |
|
|
(73,898 |
) |
|
|
(201,112 |
) |
|
|
(155,175 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Interest income |
|
|
1,985 |
|
|
|
220 |
|
|
|
2,803 |
|
|
|
545 |
|
Interest expense |
|
|
(3,157 |
) |
|
|
(6 |
) |
|
|
(5,631 |
) |
|
|
(13 |
) |
Change in fair value of warrants |
|
|
— |
|
|
|
(20,363 |
) |
|
|
— |
|
|
|
(69,082 |
) |
Other income, net |
|
|
194 |
|
|
|
13 |
|
|
|
210 |
|
|
|
40 |
|
Loss before income taxes |
|
|
(110,698 |
) |
|
|
(94,034 |
) |
|
|
(203,730 |
) |
|
|
(223,685 |
) |
Income tax expense |
|
|
(23 |
) |
|
|
(6 |
) |
|
|
(48 |
) |
|
|
(49 |
) |
Net loss |
|
|
(110,721 |
) |
|
|
(94,040 |
) |
|
|
(203,778 |
) |
|
|
(223,734 |
) |
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustment |
|
|
(108 |
) |
|
|
(19 |
) |
|
|
(133 |
) |
|
|
8 |
|
Unrealized loss on marketable securities |
|
|
(1,862 |
) |
|
|
— |
|
|
|
(7,642 |
) |
|
|
— |
|
Total comprehensive loss |
|
$ |
(112,691 |
) |
|
$ |
(94,059 |
) |
|
$ |
(211,553 |
) |
|
$ |
(223,726 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Net loss per share: |
|
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
$ |
(0.43 |
) |
|
$ |
(0.39 |
) |
|
$ |
(0.79 |
) |
|
$ |
(0.94 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average shares outstanding: |
|
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
|
258,589,270 |
|
|
|
240,733,497 |
|
|
|
258,439,051 |
|
|
|
238,774,515 |
|
Condensed Consolidated Balance Sheets (In thousands, except share data) |
||||||||
|
|
|
|
|
||||
|
|
(Unaudited) |
|
|
||||
Assets |
|
|
|
|
||||
Current assets |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
329,857 |
|
|
$ |
524,481 |
|
Restricted cash |
|
|
40,207 |
|
|
|
25,549 |
|
Marketable securities, short-term |
|
|
587,716 |
|
|
|
79,418 |
|
Inventories |
|
|
33,804 |
|
|
|
29,668 |
|
Prepaid expenses and other current assets |
|
|
18,576 |
|
|
|
19,476 |
|
Total current assets |
|
|
1,010,160 |
|
|
|
678,592 |
|
Marketable securities, long-term |
|
|
164,777 |
|
|
|
301,463 |
|
Property, plant, and equipment, net |
|
|
49,183 |
|
|
|
47,498 |
|
Other non-current assets |
|
|
44,356 |
|
|
|
41,281 |
|
Total assets |
|
$ |
1,268,476 |
|
|
$ |
1,068,834 |
|
Liabilities and Stockholders' Equity |
|
|
|
|
||||
Current liabilities |
|
|
|
|
||||
Accounts payable |
|
$ |
12,768 |
|
|
$ |
9,237 |
|
Accrued liabilities |
|
|
36,707 |
|
|
|
28,787 |
|
Customer deposits |
|
|
104,596 |
|
|
|
90,863 |
|
Other current liabilities |
|
|
2,803 |
|
|
|
2,636 |
|
Total current liabilities |
|
|
156,874 |
|
|
|
131,523 |
|
Non-current liabilities |
|
|
|
|
||||
Convertible senior notes, net |
|
|
414,563 |
|
|
|
— |
|
Other long-term liabilities |
|
|
46,464 |
|
|
|
43,047 |
|
Total liabilities |
|
|
617,901 |
|
|
|
174,570 |
|
Stockholders' equity |
|
|
|
|
||||
Preferred stock, |
|
|
— |
|
|
|
— |
|
Common stock, |
|
|
26 |
|
|
|
26 |
|
Additional paid-in capital |
|
|
1,987,614 |
|
|
|
2,019,750 |
|
Accumulated deficit |
|
|
(1,327,421 |
) |
|
|
(1,123,643 |
) |
Accumulated other comprehensive income |
|
|
(9,644 |
) |
|
|
(1,869 |
) |
Total stockholders' equity |
|
|
650,575 |
|
|
|
894,264 |
|
Total liabilities and stockholders' equity |
|
$ |
1,268,476 |
|
|
$ |
1,068,834 |
|
Condensed Consolidated Statements of Cash Flows (Unaudited and in thousands) |
||||||||
|
|
|
||||||
|
|
Six Months Ended |
||||||
|
|
2022 |
|
2021 |
||||
Cash flows from operating activities |
|
|
|
|
||||
Net loss |
|
$ |
(203,778 |
) |
|
$ |
(223,734 |
) |
Stock-based compensation |
|
|
22,978 |
|
|
|
36,535 |
|
Depreciation and amortization |
|
|
5,767 |
|
|
|
5,740 |
|
Amortization of debt issuance costs |
|
|
841 |
|
|
|
— |
|
Change in fair value of warrants |
|
|
— |
|
|
|
69,082 |
|
Other operating activities, net |
|
|
241 |
|
|
|
(17 |
) |
Change in assets and liabilities |
|
|
|
|
||||
Inventories |
|
|
(4,136 |
) |
|
|
518 |
|
Other current and non-current assets |
|
|
1,410 |
|
|
|
319 |
|
Accounts payable and accrued liabilities |
|
|
10,109 |
|
|
|
(751 |
) |
Customer deposits |
|
|
13,733 |
|
|
|
(1,252 |
) |
Other current and non-current liabilities |
|
|
(125 |
) |
|
|
88 |
|
Net cash used in operating activities |
|
|
(152,960 |
) |
|
|
(113,472 |
) |
Cash flows from investing activity |
|
|
|
|
||||
Capital expenditures |
|
|
(6,293 |
) |
|
|
(1,647 |
) |
Purchases of marketable securities |
|
|
(379,254 |
) |
|
|
— |
|
Cash used in investing activity |
|
|
(385,547 |
) |
|
|
(1,647 |
) |
Cash flows from financing activities |
|
|
|
|
||||
Payments of lease obligations |
|
|
(66 |
) |
|
|
(69 |
) |
Proceeds from convertible senior notes |
|
|
425,000 |
|
|
|
— |
|
Debt issuance costs |
|
|
(11,278 |
) |
|
|
— |
|
Capped call premium |
|
|
(52,318 |
) |
|
|
— |
|
Proceeds from issuance of common stock pursuant to stock options exercised |
|
|
49 |
|
|
|
12,965 |
|
Transaction costs |
|
|
— |
|
|
|
(274 |
) |
Withholding taxes paid on behalf of employees on net settled stock-based awards |
|
|
(2,846 |
) |
|
|
(11,803 |
) |
Net cash provided by financing activities |
|
|
358,541 |
|
|
|
819 |
|
Net decrease in cash and cash equivalents |
|
|
(179,966 |
) |
|
|
(114,300 |
) |
Cash, cash equivalents and restricted cash at beginning of year |
|
|
550,030 |
|
|
|
678,955 |
|
Cash, cash equivalents and restricted cash ending balances |
|
$ |
370,064 |
|
|
$ |
564,655 |
|
|
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
329,857 |
|
|
$ |
551,624 |
|
Restricted cash |
|
|
40,207 |
|
|
|
13,031 |
|
Cash, cash equivalents and restricted cash |
|
$ |
370,064 |
|
|
$ |
564,655 |
|
Use of Non-GAAP Financial Measures (Unaudited)
This press release references certain financial measures that are not prepared in accordance with generally accepted accounting principles in
The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.
A reconciliation of Adjusted EBITDA to net loss for the three and six months ended
Amounts in thousands ($) |
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
Net Loss |
|
$ |
(110,721 |
) |
|
$ |
(94,040 |
) |
|
$ |
(203,778 |
) |
|
$ |
(223,734 |
) |
Income tax expense |
|
|
23 |
|
|
|
6 |
|
|
|
48 |
|
|
|
49 |
|
Interest expense |
|
|
3,157 |
|
|
|
6 |
|
|
|
5,631 |
|
|
|
13 |
|
Depreciation & amortization |
|
|
2,915 |
|
|
|
2,871 |
|
|
|
5,767 |
|
|
|
5,740 |
|
Stock-based compensation |
|
|
12,083 |
|
|
|
14,423 |
|
|
|
22,978 |
|
|
|
36,535 |
|
Change in fair value of warrants |
|
|
— |
|
|
|
20,363 |
|
|
|
— |
|
|
|
69,082 |
|
Adjusted EBITDA |
|
$ |
(92,543 |
) |
|
$ |
(56,371 |
) |
|
$ |
(169,354 |
) |
|
$ |
(112,315 |
) |
A reconciliation of selling, general, and administrative expenses to non-GAAP selling, general, and administrative expenses for the three and six months ended
Amounts in thousands ($) |
|
Three Months Ended |
|
Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
Selling, general, and administrative |
|
$ |
44,700 |
|
$ |
36,916 |
|
$ |
81,707 |
|
$ |
80,235 |
Stock-based compensation |
|
|
8,650 |
|
|
10,426 |
|
|
15,942 |
|
|
28,465 |
Non-GAAP selling, general, and administration expenses |
|
$ |
36,050 |
|
$ |
26,490 |
|
$ |
65,765 |
|
$ |
51,770 |
A reconciliation of research and development expenses to non-GAAP research and development expenses for the three and six months ended
Amounts in thousands ($) |
|
Three Months Ended |
|
Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
Research and development |
|
$ |
62,340 |
|
$ |
34,619 |
|
$ |
114,167 |
|
$ |
69,708 |
Stock-based compensation |
|
|
3,433 |
|
|
3,997 |
|
|
7,037 |
|
|
8,070 |
|
|
$ |
58,907 |
|
$ |
30,622 |
|
$ |
107,130 |
|
$ |
61,638 |
The following table reconciles forecasted net cash used in operating activities to forecasted free cash flow for the third quarter of 2022 (in thousands):
|
|
|
Net cash used in operating activities |
|
( |
Capital expenditures |
|
( |
Free cash flow |
|
( |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220804005994/en/
For media inquiries:
Aleanna Crane - Vice President Communications
Virgingalacticpress@virgingalactic.com
575.800.4422
For investor inquiries:
vg-ir@virgingalactic.com
Source:
FAQ
What were Virgin Galactic's financial results for Q2 2022?
When is Virgin Galactic's commercial service expected to launch?
What new developments has Virgin Galactic announced recently?